Epidemiology of Perioperative Care in Sweden (EPeCS)

February 21, 2025 updated by: Rasmus Åhman, Linkoeping University

EPeCS - Epidemiology of Perioperative Care in Sweden 2015-2020

The Epidemiology of Perioperative Care in Sweden (EPeCS) study is a registry-based, retrospective extensive analysis of the whole adult (≥18 years) surgical population in Sweden during six full years, 1 January 2015 - 31 December 2020. Patients are retrieved from the Swedish Perioperative Registry (SPOR) which has full national coverage of public healthcare.

The study aspire to integrate pre-, peri- and postoperative components of the whole perioperative process as well as process, patient, anaesthesia and surgical factors. This allows for careful risk-adjustment and is a major strength of the project. This will require cross-matching data from several national quality registries.

EPeCS will serve as a database to be used as the foundation for several substudies that are to be conducted (10 at the present moment). Specific study focuses and aims are described in the "Detailed Description" section below.

The present study aims to provide a comprehensive audit of the surgical population in Sweden, and to identify factors that are of importance for outcome. The investigators aim to identify factors that will allow a better prediction of outcome, if they are modifiable, and if they are different for different lengths of follow-up. The ultimate goal is to provide hypotheses for directed therapies (eg. different types of anaesthesia), processes (eg. designated around-the-clock hip-fracture surgical teams), postoperative care (eg. extended PACU care instead of intensive care) in order to decrease suffering and increase cost-efficacy in Swedish healthcare.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

Specific aim for each substudy:

  1. Epidemiology of Perioperative Care in Sweden
  2. Risk factors for mortality after acute hip fracture surgery
  3. Healthcare need after surgery
  4. outcomes after urgent and emergency surgery
  5. impact of estimated glomerular filtration rate (eGFR) on survival after elective surgery
  6. effect of angiotensin receptor blocker (ARB) and angiotensin converting enzyme inhibitor (ACEi) non-resumption on postoperative outcome
  7. impact of socioeconomic status
  8. impact of university hospital status
  9. effect of body mass index (BMI)
  10. effect of post-anaesthesia care unit (PACU) stay

All these 10 specific areas have knowledge gaps regarding perioperative care.

Although there are 10 specific aims in this project, the same dataset (or parts thereof) from SPOR will be used for all substudies. The investigators will include all adult patients (≥18 years) undergoing any surgical procedure, except for the substudies where specific populations are prespecified, which are substudy 2: hip fracture surgery; substudy 4: urgent and emergency procedures; substudies 5,6 and 10: elective procedures with planned overnight stay; substudies 7 and 8: large joint surgery (hip and knee replacements), acute hip fracture surgery, colectomy, mastectomy, transurethral resection of the prostate (TUR-P) and prostatectomy.

Outcome measures might also differ between substudies.

National Quality Registries that will provide data for EPeCS, presented as "register (registry holder)":

  • Swedish Perioperative Registry, SPOR (Uppsala Clinical Research Centre, UCR)
  • Longitudinal integrated database for health insurance and labour market studies, LISA (Statistics Sweden)
  • Swedish National Inpatient Register (the National Board of Health and Welfare)
  • Swedish National Outpatient Register (the National Board of Health and Welfare)
  • Swedish Drug Register (the National Board of Health and Welfare)
  • Swedish Cause of death Register (the National Board of Health and Welfare)

The impetus for this project comes from the realization that surgery is not just a discrete event - it is part of a continuum of a larger journey of illness and health. The investigators hope to gain a comprehensive understanding of those patients who are at risk of poor outcome, their risk of death and burden of healthcare need after surgery.

Additional substudies might emerge.

Study Type

Observational

Enrollment (Estimated)

1500000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Östergötland
      • Linköping, Östergötland, Sweden, 50185
        • Department of Anaesthesia and Intensive Care, Linkoeping University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

All adult (≥18 years) patients that have undergone any type of surgical procedure during 1 Jan 2015 - 31 Dec 2020 and are registered in the Swedish Perioperative Registry (SPOR).

Description

Inclusion Criteria:

  • Underwent any surgical procedure in Sweden during the time period 1 Jan 2015 - 31 Dec 2020
  • Registered in the Swedish Perioperative Registry (SPOR)
  • ≥18 years of age
  • Swedish social security number (to enable follow-up)

Exclusion Criteria:

  • incorrect social security number
  • incomplete mortality data
  • the patient has chosen to opt-out of the register

The first two exclusion criteria are applied because they prevent correct follow-up of the primary outcome measure (mortality)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
The Swedish surgical population
All adult patients (≥18 years) undergoing any surgical procedure registered in SPOR during 1 January 2015 - 31 December 2020.
Might differ for substudies.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30-day mortality
Time Frame: Mortality up to 30 days post-surgery
all cause
Mortality up to 30 days post-surgery
90-day mortality
Time Frame: Mortality up to 90 days post-surgery
all cause
Mortality up to 90 days post-surgery
One-year mortality
Time Frame: Mortality up to one year post-surgery
all cause
Mortality up to one year post-surgery
Two-year mortality
Time Frame: Mortality up to two years post-surgery
all cause
Mortality up to two years post-surgery
Survival at longest follow-up
Time Frame: Longest possible follow-up post-surgery
Survival rate through study completion, an average of 3 years
Longest possible follow-up post-surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative complications
Time Frame: 30 days (short-term) and one year (long-term) post-surgery, respectively
Any new ICD10-SE code specified in SPOR
30 days (short-term) and one year (long-term) post-surgery, respectively
Healthcare need
Time Frame: Two years post-surgery
Number of primary care visits
Two years post-surgery
Critical Care need
Time Frame: 30 days post-surgery
Admission to a critical care unit after surgery
30 days post-surgery
Hospital readmission
Time Frame: 30 days post-surgery
Readmission to hospital care after discharge
30 days post-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Michelle S Chew, MD, PhD, Linkoeping University
  • Principal Investigator: Rasmus Åhman, MD, Linkoeping University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Actual)

February 1, 2023

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

September 22, 2022

First Submitted That Met QC Criteria

September 27, 2022

First Posted (Actual)

September 29, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 21, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Any surgical procedure

Subscribe